TBIO
Telesis Bio, Inc. Common Stock
TBIO
TBIO
Delisted
TBIO was delisted on the 27th of September, 2024.
37 hedge funds and large institutions have $26.1M invested in Telesis Bio, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 4 increasing their positions, 19 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
79% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 19
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Holders
37
Holding in Top 10
1
Calls
–
Puts
$3K
Top Buyers
| 1 | +$944K | |
| 2 | +$330K | |
| 3 | +$75.7K | |
| 4 |
E
Ergoteles
New York
|
+$71K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$57K |
Top Sellers
| 1 | -$7.06M | |
| 2 | -$3.13M | |
| 3 | -$1.61M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$696K |
| 5 |
BlackRock
New York
|
-$662K |